Table 3. RILI treatment.
| Grade | Treatment |
|---|---|
| Grade 1: no symptom | No treatment required |
| Radiotherapy pauses | |
| Monitor every 2–3 days | |
| Grade 2: symptom (cough, shortness of breath, chest pain) | Delay oncological treatment |
| GCs treatment: prednisone 0.5–1 mg/kg/day orally | |
| Start antibiotics if infection is suspected | |
| Alert pneumocystis prophylaxis | |
| ≥ Grade 3: hypoxia, respiratory failure, life threatening, ARDS | Stop oncological treatment |
| Hospitalization | |
| Respiratory support | |
| Imaging, bacterial, hematological examination | |
| Application of broad-spectrum antibiotics | |
| GCs treatment: methylprednisolone 2–4 mg/kg/day IV | |
| Alert pneumocystis prophylaxis and GI prophylaxis |
RILI, radiation-induced lung injury; GCs, glucocorticoids; ARDS, acute respiratory distress syndrome; GI, gastrointestinal; IV, intravenous.